We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use an ethnographic study to evaluate your digital health product.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
How to use an N-of-1 study to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
How to use an interrupted time series to evaluate your digital health product.
How to use a before-and-after study to evaluate your digital health product.
How to use routinely collected data to evaluate your digital health product.
How the UK's strategic export controls apply to academics, university researchers and their institutions, and when an export licence is needed.
An outline of the delivery patterns that are outside of standard delivery.
How to use a case-control study to evaluate your digital health product.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
How to use a cost utility analysis to evaluate your digital health product.
This contains important actions and clarifications for institutions delivering 16 to 19 study programmes.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use a think aloud study to evaluate your digital health product.
This contains important actions and clarifications for institutions delivering 16 to 19 provision.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).